Literature DB >> 5022020

Hazard of immunosuppressive therapy.

N Manny, E Rosenman, J Benbassat.   

Abstract

Mesh:

Substances:

Year:  1972        PMID: 5022020      PMCID: PMC1788976          DOI: 10.1136/bmj.2.5808.291

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  4 in total

Review 1.  Immunosurveillance and cancer.

Authors:  D Keast
Journal:  Lancet       Date:  1970-10-03       Impact factor: 79.321

2.  Immunosurveillance and cancer: epidemiological evidence.

Authors:  R Doll; L Kinlen
Journal:  Br Med J       Date:  1970-11-14

3.  Immunological aspects of neoplasia: a rational basis for immunotherapy.

Authors: 
Journal:  Ann Intern Med       Date:  1971-04       Impact factor: 25.391

Review 4.  Cancer and arthritis.

Authors:  J J Calabro
Journal:  Arthritis Rheum       Date:  1967-12
  4 in total
  4 in total

Review 1.  [The immunology of malignant melanoma (author's transl)].

Authors:  G Schieferstein
Journal:  Klin Wochenschr       Date:  1978-03-15

2.  Immunosuppression and malignancy.

Authors: 
Journal:  Br Med J       Date:  1972-09-23

3.  Proceedings: The effect of immunosuppression on cancer.

Authors:  I Penn; T E Starzl
Journal:  Proc Natl Cancer Conf       Date:  1972

4.  Therapeutic workshop on modifying the disease process in rheumatoid arthritis: immunosuppression in perspective.

Authors: 
Journal:  Ann Rheum Dis       Date:  1982       Impact factor: 19.103

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.